U of U startup builds next-gen CAR-T platform for multiple cancers
Spinout NanoKar Therapeutics is developing a way to fine-tune existing CAR-T treatments so the cells can last longer and work more effectively.
Read MoreSpinout NanoKar Therapeutics is developing a way to fine-tune existing CAR-T treatments so the cells can last longer and work more effectively.
Read MoreResearch shows how the bacteria in the gut shape the immune system.
Read More